Marketing authorisation for a medicine Medical devices Application for general reimbursement Inspection of pharmaceutical companies Company authorisations and registrations DKMAnet Clinical trials of medicines Fees Product defects and withdrawals
Theme

Strategy for the DKMA

The Danish Medicines Agency has formulated a strategy for 2022-26. The strategy emphasizes a vision of leading the way in national and international cooperation, and in the dialogue with citizens and society. Read more.

Go to theme
Theme

Vaccines and medicines against COVID-19

Read about the current studies and development of vaccines and medicines for treatment of COVID-19, and how medicines can be approved much quicker in extraordinary situations, if patient safety is sufficiently assured.

Go to theme

News and notifications

Nils Falk Bjerregaard new Director General of the Danish Medicines Agency

03 October 2024

The Danish Ministry of the Interior and Health has appointed Medical Director Nils Falk Bjerregaard as Director General of the Danish Medicines Agency as of 1 November 2024.

Completion of the project regarding the control of anti-tampering devices (ATD) on medicinal product packages

12 September 2024

New regulations on Stockpiling of Critical Medicines effective on July 1 2024

01 July 2024

Status for the project regarding the control of anti-tampering devices (ATD) on medicinal product packages

25 April 2024